Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. Issue 2 (December 2015) - Linch, Stefanie; Kasiewicz, Melissa; McNamara, Michael; Hilgart-Martiszus, Ian; Farhad, Mohammad; Redmond, William